MDS: Treatment paradigms are changing
hemato-oncology, Tracking Studies, Syndicated Studies, Oncology
MyeloDysplastic Syndromes: our syndicated research will tell you why - and how - treatment paradigms are changing. Our results from first 2 waves conducted are available now and field is running for the 3rd wave.